Moors & Cabot’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.3M | Buy |
339,461
+158,831
| +88% | +$5.9M | 0.52% | 44 |
|
|
2026
Q1 | $7.23M | Sell |
180,630
-150,118
| -45% | -$7.1M | 0.31% | 64 |
|
|
2025
Q4 | $14.9M | Sell |
330,748
-22,061
| -6% | -$1.02M | 0.64% | 31 |
|
|
2025
Q3 | $15.8M | Buy |
352,809
+154,851
| +78% | +$7.41M | 0.69% | 29 |
|
|
2025
Q2 | $9.51M | Buy |
197,958
+114,289
| +137% | +$4.97M | 0.44% | 45 |
|
|
2025
Q1 | $3.36M | Sell |
83,669
-403
| -0.5% | -$17K | 0.17% | 117 |
|
|
2024
Q4 | $3.85M | Buy |
84,072
+414
| +0.5% | +$18.5K | 0.18% | 110 |
|
|
2024
Q3 | $3.92M | Hold |
83,658
| – | – | 0.19% | 104 |
|
|
2024
Q2 | $3.54M | Hold |
83,658
| – | – | 0.19% | 110 |
|
|
2024
Q1 | $3.7M | Buy |
83,658
+50
| +0.1% | +$2.28K | 0.2% | 106 |
|
|
2023
Q4 | $3.85M | Buy |
83,608
+25
| +0% | +$1.06K | 0.24% | 96 |
|
|
2023
Q3 | $3.59M | Hold |
83,583
| – | – | 0.24% | 93 |
|
|
2023
Q2 | $3.99M | Buy |
83,583
+27
| +0% | +$1.3K | 0.27% | 88 |
|
|
2023
Q1 | $4.07M | Hold |
83,556
| – | – | 0.28% | 89 |
|
|
2022
Q4 | $4.42M | Hold |
83,556
| – | – | 0.31% | 76 |
|
|
2022
Q3 | $3.66M | Hold |
83,556
| – | – | 0.28% | 81 |
|
|
2022
Q2 | $4.18M | Hold |
83,556
| – | – | 0.3% | 78 |
|
|
2022
Q1 | $4.34M | Hold |
83,556
| – | – | 0.27% | 87 |
|
|
2021
Q4 | $4.92M | Hold |
83,556
| – | – | 0.3% | 75 |
|
|
2021
Q3 | $4.58M | Buy |
83,556
+47,695
| +133% | +$2.66M | 0.29% | 77 |
|
|
2021
Q2 | $1.84M | Hold |
35,861
| – | – | 0.13% | 166 |
|
|
2021
Q1 | $1.85M | Hold |
35,861
| – | – | 0.14% | 151 |
|
|
2020
Q4 | $2.01M | Hold |
35,861
| – | – | 0.17% | 138 |
|
|
2020
Q3 | $1.99M | Buy |
+35,861
| New | +$1.86M | 0.19% | 118 |
|
|
2020
Q2 | – | Sell |
-44,820
| Closed | -$1.98M | – | 694 |
|
|
2020
Q1 | $1.98M | Hold |
44,820
| – | – | 0.29% | 86 |
|
|
2019
Q4 | $1.61M | Sell |
44,820
-141
| -0.3% | -$5.24K | 0.16% | 140 |
|
|
2019
Q3 | $1.57M | Hold |
44,961
| – | – | 0.17% | 140 |
|
|
2019
Q2 | $1.93M | Hold |
44,961
| – | – | 0.25% | 104 |
|
|
2019
Q1 | $1.94M | Buy |
44,961
+34,138
| +315% | +$1.37M | 0.26% | 101 |
|
|
2018
Q4 | $395K | Buy |
10,823
+189
| +2% | +$7.02K | 0.06% | 299 |
|
|
2018
Q3 | $427K | Hold |
10,634
| – | – | 0.05% | 348 |
|
|
2018
Q2 | $407K | Buy |
+10,634
| New | +$391K | 0.05% | 344 |
|
Other funds holding QGEN
Moors & Cabot's QGEN Position: Q2 2026 in Review
Moors & Cabot increased its Qiagen (QGEN) stake by 88% in Q2 2026, buying an estimated $5.9M and bringing the position to 339,461 shares worth $13.3M. The position accounts for 0.52% of the portfolio, ranked #44.
Moors & Cabot first reported a position in QGEN in Q2 2018 and has held it in 32 quarters since. The position peaked at $15.8M in Q3 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- Moors & Cabot held 339,461 shares of Qiagen worth $13.3M as of Q2 2026.
- Moors & Cabot bought 158,831 Qiagen shares in Q2 2026, an estimated $5.9M.
- Qiagen made up 0.52% of Moors & Cabot's portfolio in Q2 2026, its #44 holding.
- Moors & Cabot first reported a position in Qiagen in Q2 2018 and has held it in 32 quarters since.
- Moors & Cabot's Qiagen position peaked at $15.8M in Q3 2025.
- 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.